Webcasts & Presentations

Neurocrine’s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com

Neurocrine Announces PhII Results of VMAT2 Inhibitor INGREZZA® for Treatment of Tourette Syndrome
May 23, 2017 at 5:00pm ET (2:00pm PT)
INGREZZA Tourette WebcastThis link is used for real-time and archive audio through June 23, 2017

Neurocrine Presents at the Bank of America Merrill Lynch 2017 Healthcare Conference in Las Vegas
May 17, 2017  at 8:40amPT (11:40amET)
BAML Webcast 
This link is used for real-time and archive audio through June 17, 2017

Neurocrine Reports First Quarter 2017 Results
May 9, 2017  at 5:00pmET (2:00pmPT)
Earnings Webcast 
This link is used for real-time and archive audio through June 9, 2017

 

CORPORATE PRESENTATION (PDF) This presentation provides an overview of our company pipeline, program progress, and financial highlights.